Viewing Study NCT06850766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-04-10 @ 3:55 AM
Study NCT ID: NCT06850766
Status: RECRUITING
Last Update Posted: 2025-11-28
First Post: 2025-02-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
Sponsor: Ottawa Hospital Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None IDH-Wildtype Glioblastoma View
None Glioblastoma (GBM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None temozolomide View
None chronotherapy View
None dose timing View
None cancer View
None oncology View
None glioblastoma View
None chemotherapy View